Brief: Transcode Therapeutics Announces Publication Of New Data Supporting The Use Of TTX-MC138 For The Treatment Of Metastatic Breast Cancer
22/06/2023 12:35
June 22 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS ANNOUNCES PUBLICATION OF NEW DATA
SUPPORTING THE USE OF TTX-MC138 FOR THE TREATMENT OF METASTATIC
BREAST CANCER
Source text for Eikon: ID:nGNX2wc4zh
Further company coverage: RNAZ.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors